PC-CIS Tools and Guides
Index of Blueprint Tools, Resources, and Examples
EveryLife Foundation Guide to Patient Involvement in Rare Disease Therapy Development |
Patient-Centered Outcomes Research Institute (PCORI) Patient and Family Engagement Rubric |
Patient-Focused Medicines Development’s (PFMD) Patient Engagement Management Suite includes several resources including these How-To Guides and guidance on high-quality engagement |
The Patient-Led Research Collaborative, a “self-organized group of Long COVID patients working on patient-led research around the Long COVID experience” |
The National Health Council Rubric to Capture the Patient Voice |
The National Health Council Representativeness Rubric and Roadmap |
The Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Handbook Principles, Chapter 3, Section C engagement |
Patient-Important Outcomes in the Long-Term Treatment of Bipolar Disorder Case Example |
The Harmonizing Outcome Measures for Eczema (HOME) Roadmap for C0re Outcome Sets (COS) Development |
Patient and family engagement in the development of two rare disease COS |
Parent Project Muscular Dystrophy (PPMD) repository of activities |
Juvenile Idiopathic Arthritis Patient-Focused Drug Development (PFDD) Meeting Voice of the Patient Report |
Lupus Collaborative Voice of the Patient Report |
Patient-Centered Outcomes Research Institute (PCORI)-funded Patient-Powered Research Network (PPRN), iConquerMS |
Improve Care Now, an Inflammatory Bowel Disease (IBD) research platform |
The Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Principles on patient engagement, Chapter 3, Section C |
The Patient-Centered Outcomes Research Institute (PCORI) guidance for building and maintaining multi-stakeholder collaborations. |
Stakeholder Engagement in Research Studies Toolkit |
TOPPER/HIPXChange Toolkit |
Partnership and Infrastructure to Support Patient & Stakeholder Engagement: A Scan of PCORnet Practices |
Patient-Focused Medicines Development’s (PFMD) Patient Engagement Management (PEM) Suite includes several resources including these How-To Guides |
HIPxChange Deeply Engaging Patients with a Mix & Match of Methods |
The National Health Council Rubric to Capture the Patient Voice and Representativeness Rubric and Roadmap |
Stakeholder mapping tool ensure the full complement of inputs are being leveraged |
OMERACT Handbook for patient engagement in outcome measure efforts |
Stakeholder Engagement in Research Studies Toolkit |
TOPPER/HIPXChange Toolkit |
Partnership and Infrastructure to Support Patient & Stakeholder Engagement: A Scan of PCORnet Practices |
PRISMA tool for stakeholder mapping |
Center for Medical Technology Policy (CMTP) coreHEM final report (consult page 6) provides guidance on ensuring patient-prioritized items are appropriately retained |
University of Maryland’s Patient-Driven Value in Healthcare Evaluation (PAVE) Center’s framework for prioritization |
De-identified Budget from a U.S Food & Drug Administration (FDA) Patient-Focused Drug Development Meeting |
De-identified Budget from a Patient-Centered Outcomes Research Institute (PCORI) Engagement Award |
The Improve Care Now sponsorship page reflects the wide array of potential funders for such work including individual donors, banks, foundations, and federal partners. |
The National Health Council Fair-Market Value calculator |
Patient-Centered Outcomes Research Institute (PCORI) Framework for Compensation |
The NHC’s Standards of Excellence Certification Program for Voluntary Health Agencies Guidance |
PCORI Engagement Award Funding Opportunities |
U.S Food & Drug Administration (FDA)-Led Patient-Focused Drug Development (PFDD) Public Meetings website |
RARE-X Patient-Powered registry |
Duchenne Data registry |
FDA Voice of the Patient Reports (pediatric asthma (VOP pending),JIA, UMDF |
Patient-group led Voice-of-the-Patient Report, National Kidney Foundation |
Patient-group led Voice-of-the-Patient Report, Arthritis Foundation. |
Patient-group led Voice-of-the-Patient Report, United Mitochondrial Disease Foundation |
RARE-X Patient-Powered registry |
Duchenne Data registry |
Juvenile Idiopathic Arthritis (JIA) PFDD Voice of the Patient Report |
Lupus Collaborative Voice of the Patient Report |
PCORI-funded Patient-Powered Research Network (PPRN), iConquerMS |
Improve Care Now, an IBD research platform |
The Patient-Led Research Collaborative, a “self-organized group of Long COVID patients working on patient-led research around the Long COVID experience” |
Patient and family engagement in the development of two rare disease Core Outcome Sets (COS) |
Patient-Centered Outcomes Research Institute (PCORI) Research Fundamentals Training |
Multi-Method Patient-Engagement Approach: A case example from a PCORI-Funded Training Project. |
The Kaiser Foundation Patient Engagement Toolkit and Guidance for training and engaging patients in data analysis |
HIPxChange Deeply Engaging Patients with a Mix & Match of Methods |
Patient-Focused Medicines Development’s (PFMD) Patient Engagement Management Engagement Training |
The Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Handbook for patient engagement in outcome measure efforts |
U.S. Food & Drug Administration’s (FDA’s) Patient-Focused Drug Development (PFDD) Guidance 1, Focus Group guidance |
NHC Patient Experience Mapping Toolbox (PEMT) Interviewer Training Guide and Project Coordinator Guide pages 4-7 |
FDA’s PFDD Guidance 1, Focus Group guidance |
Patient-Centered Outcomes Research Institute (PCORI) Methodology Standards for Patient-Centeredness |
FDA PFDD data collection guidance |
University of Maryland PCORI project methods guidance |
FDA Patient-Focused Drug Development Guidance 1 |
FDA Patient-Focused Drug Development Guidance 2 |
Innovative Medicines Initiative Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) Patient Preference Methodology |
A resource on understanding Triangulation |
The Core Outcome Measures in Effectiveness Trials (COMET) plain-language summaries of methods for nominal group technique and Delphi process |
Medical Device Innovation Consortium (MDIC)’s catalog of methods |
INVOLVE UK Delphi Methods Description |
Systematic Review of Patient participation in Delphi surveys to develop core outcome sets |
PATHWAY Programme Stated Preference Case Example |
Arthritis Foundation Live Yes! INSIGHTS Methodology Description |
Cystic Fibrosis Foundation Discrete Choice Analysis Case Example |
Co-creation and prioritization guidance from Patient Focused Medicines Development project |
European Union’s Responsible Research & Innovation guidance |
The Center for Medical Technology (CMTP) and Policy Core Outcome Sets (COS) Projects and methodology |
CMTP coreHEM final report |
NHC Patient Experience Mapping Toolbox (PEMT) Interviewer Training Guide and Project Coordinator Guide pages 4-7 |
University of Maryland’s Patient-Driven Value in Healthcare Evaluation (PAVE) Center’s framework for prioritization |
University of Maryland “What Works When” methods guidance |
National Health Council and Duke University Real-World Evidence training webinar series |
The National Health Council’s Developing Patient-Centered Real-World Evidence manuscript and White Paper and Real World Evidence classroom |
PFMD Book of Good Practices |
Patient-Focused Medicines Development’s (PFMD) Synapse |
The Core Outcome Measures in Effectiveness Trials (COMET) database |
Parent Project Muscular Dystrophy repository of activities |
The Core Outcome Set- STAndards for Reporting (COS-STAR) Guidelines for reporting resource |
The Core Outcome Set-STAdards for Development (COS-STAD) standards for developing a Core Outcome Set (COS) |
COS-STAR guidance to describe geographic diversity of stakeholders. |
The Center for Medical Technology and Policy COS Projects and methodology |
Innovation and Value Initiative’s Open Source principles on how to transparently and accessibly communicate |
The International Society for Pharmacoeconomics and Outcomes Research (PCORI) Open Source Models Special Interest Group (SIG) publications and convening on barriers and facilitators to most transparently sharing methods and processes |